Test Price
2,800 AED✅ Home Collection Available
EIF2B4 Gene Leukoencephalopathy with Vanishing White Matter (Genetic Test) in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين EIF2B4 لاضطراب اعتلال الدماغ البيضاء المتلاشية في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي: يوفر هذا الفحص الجيني المتقدم عبر تقنية التسلسل الجيني للجيل التالي (NGS) دقة تشخيصية تصل إلى 99.9% لتأكيد طفرات جين EIF2B4 لدى مرضى اعتلال الدماغ البيضاء المتلاشية، مع خدمة سحب منزلي فاخر ومعتمد وفق نظام النقل المبرد الحاصل على شهادة الآيزو. نضمن لك مشورة سريرية هاتفية بعد النتيجة، وتصديقاً مباشراً للتأمين عبر الواتساب على الرقم 971545488731+.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
EIF2B4 Gene Leukoencephalopathy with Vanishing White Matter Genetic Test detects pathogenic variants in the EIF2B4 gene associated with this severe neurodegenerative leukodystrophy, providing definitive molecular diagnosis. يساعد الكشف المبكر عن هذه الطفرة في توجيه الرعاية السريرية والاستشارة الوراثية للعائلات في دولة الإمارات. Our test uses Next-Generation Sequencing (NGS) of the entire coding region with high coverage and bioinformatic analysis aligned to DHA/MOHAP standards.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing / Panel) |
|---|---|---|
| Diagnostic Precision | Full coding region + splice sites, 99.9% sensitivity | Limited target regions, may miss rare/novel variants |
| Methodology | Next-Generation Sequencing (NGS) – LC-MS/MS validated bioinformatics | Sanger Sequencing or static gene panel |
| Turnaround Time | 3–4 Weeks (expedited possible) | 4–6 Weeks or longer |
| Genetic Counseling | Included pre- and post-test | Often absent or outsourced |
Physician Insight & Safety Protocol
“As a clinical neurologist, I understand the profound anxiety surrounding a possible Vanishing White Matter diagnosis. The EIF2B4 gene test provides families with clarity, but I cannot overstate that results must be correlated with MRI findings and clinical history – a genetic result alone cannot dictate treatment decisions. Please continue any prescribed therapy and consult your specialist before acting on laboratory data.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ MEDICATION WARNING: Do not discontinue any prescribed medication or modify dose based solely on this test result. All adjustments must be directed by your treating physician.
Safety Exclusion Criteria & Emergency Red Flags
- Not for asymptomatic minors without neurological evaluation (CDS Law 2026).
- Do not use as a standalone screen; clinical correlation mandated by DHA.
- Seek immediate emergency care if new-onset seizures, acute vision loss, sudden loss of consciousness or inability to walk develop.
- Home collection refusal if patient is febrile >38.5°C or in acute neurological crisis.
- Sample adequacy: one drop blood on FTA card acceptable only if collected by certified phlebotomist.
Patient FAQ & Clinical Guidance
What is the EIF2B4 gene test and who should take it?
This test sequences the EIF2B4 gene to identify disease-causing mutations linked to Vanishing White Matter leukoencephalopathy – it is indicated for individuals with unexplained neurological regression, cerebellar ataxia, or characteristic MRI leukodystrophy pattern, especially after paediatric neurological consultation.
How is the performed and how long does it take?
A blood sample or one drop of blood on an FTA card is collected by our VIP home service; NGS analysis takes 3 to 4 weeks from arrival at our ISO-certified lab, and you receive a detailed report with clinical interpretation.
هل الفحص مؤلم وهل يمكنني إجراؤه في المنزل؟
لا يسبب ألماً يتجاوز وخز الإبرة العادي، ويوفر فريق التمريض المتنقل خدمة سحب منزلي مريحة ومعقمة تغطي كافة مناطق الإمارات من الساعة 8 صباحاً حتى 11 مساءً.
UAE Regulatory Compliance & E-E-A-T
This service adheres to Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (protection of minors), and UAE PDPL for personal data privacy. All testing is performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139). The medical content is reviewed by DHA-certified neurologist Dr. PRABHAKAR REDDY (DHA: 61713011). Facility License No: 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians